SEI Investments’s NovoCure NVCR Stock Holding History

SEI Investments’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Sell	72,769 -41,512	-36%	-$628K	﹤0.01%	2249
2026 Q1	$1.25M	Buy	114,281 +89,839	+368%	+$1.12M	﹤0.01%	2246
2025 Q4	$316K	Sell	24,442 -1,567	-6%	-$20.1K	﹤0.01%	2717
2025 Q3	$336K	Buy	26,009 +8,487	+48%	+$113K	﹤0.01%	2418
2025 Q2	$312K	Buy	+17,522	New	+$305K	﹤0.01%	2396
2023 Q2	–	Sell	-6,483	Closed	-$390K	–	2733
2023 Q1	$390K	Buy	6,483 +3,434	+113%	+$274K	﹤0.01%	2231
2022 Q4	$224K	Sell	3,049 -129	-4%	-$9.71K	﹤0.01%	2310
2022 Q3	$241K	Sell	3,178 -298	-9%	-$23.2K	﹤0.01%	2391
2022 Q2	$229K	Sell	3,476 -238	-6%	-$17.9K	﹤0.01%	2439
2022 Q1	$306K	Buy	3,714 +84	+2%	+$6.19K	﹤0.01%	2304
2021 Q4	$273K	Buy	3,630 +607	+20%	+$60.9K	﹤0.01%	2362
2021 Q3	$350K	Sell	3,023 -62	-2%	-$9.37K	﹤0.01%	2249
2021 Q2	$684K	Sell	3,085 -6,732	-69%	-$1.31M	﹤0.01%	1948
2021 Q1	$1.3M	Sell	9,817 -3,685	-27%	-$583K	﹤0.01%	1646
2020 Q4	$2.34M	Sell	13,502 -6,711	-33%	-$918K	0.01%	1311
2020 Q3	$2.26M	Sell	20,213 -24,703	-55%	-$1.98M	0.01%	1235
2020 Q2	$2.66M	Buy	44,916 +10,734	+31%	+$706K	0.01%	1143
2020 Q1	$2.3M	Buy	34,182 +6,028	+21%	+$476K	0.01%	1083
2019 Q4	$2.37M	Sell	28,154 -5,883	-17%	-$475K	0.01%	1251
2019 Q3	$2.61M	Sell	34,037 -9,416	-22%	-$753K	0.01%	1213
2019 Q2	$2.68M	Sell	43,453 -4,914	-10%	-$249K	0.01%	1197
2019 Q1	$2.33M	Sell	48,367 -11,894	-20%	-$572K	0.01%	1245
2018 Q4	$3.16M	Hold	60,261	–	–	0.01%	1123
2018 Q3	$3.16M	Sell	60,261 -13,662	-18%	-$544K	0.01%	1095
2018 Q2	$2.31M	Buy	73,923 +55,000	+291%	+$1.53M	0.01%	1263
2018 Q1	$412K	Buy	18,923 +8	+0%	+$172	﹤0.01%	1674
2017 Q4	$382K	Sell	18,915 -1,095	-5%	-$21.1K	﹤0.01%	1740
2017 Q3	$397K	Buy	+20,010	New	+$393K	﹤0.01%	1695

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

SEI Investments's NVCR Position: Q2 2026 in Review

SEI Investments reduced its NovoCure (NVCR) stake by 36% in Q2 2026, selling an estimated $628K and leaving 72,769 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2249.

SEI Investments first reported a position in NVCR in Q3 2017 and has held it in 28 quarters since. The position peaked at $3.16M in Q4 2018. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

SEI Investments held 72,769 shares of NovoCure worth $1.1M as of Q2 2026.
SEI Investments sold 41,512 NovoCure shares in Q2 2026, an estimated $628K.
NovoCure made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2249 holding.
SEI Investments first reported a position in NovoCure in Q3 2017 and has held it in 28 quarters since.
SEI Investments's NovoCure position peaked at $3.16M in Q4 2018.
218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.